Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Alexza Pharmaceuticals Inc. Stories

2014-04-17 08:28:57

MOUNTAIN VIEW, Calif., April 17, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that Winston R. Brown, Jr. has joined the Company as Vice President, Quality. Mr. Brown brings more than two decades of experience in global quality, regulatory compliance and development operations working with diverse biopharmaceuticals, medical devices and nutritionals in globally integrated companies. In this position, Mr. Brown has primary responsibility for Quality...

2014-04-16 16:30:48

MOUNTAIN VIEW, Calif., April 16, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) will report results for its fiscal quarter ended March 31, 2014 on Monday, May 5, 2014, following the close of the U.S. financial markets. The Company will also host an investor conference call and live webcast on the same day at 5:00 p.m. Eastern Time / 2:00 p.m. Pacific Time to provide a company update and discuss the financial results....

2014-03-19 08:30:28

Notes Secured by Royalties and Milestones on U.S. Sales of ADASUVE® MOUNTAIN VIEW, Calif., March 19, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) (Alexza) announced today that it has closed a private placement to institutional investors of $45.0 million of non-recourse notes (the "Notes"). The Notes are secured by royalties and potential milestones from U.S. sales of ADASUVE(®) (loxapine) inhalation powder. Alexza's commercial partner for ADASUVE in the U.S....

2014-03-13 08:29:52

MOUNTAIN VIEW, Calif. and BARCELONA, Spain, March 13, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) and Ferrer today announced that ADASUVE(®) inhalation powder, pre-dispensed (loxapine) is now available in Romania. Ferrer is Alexza's commercial partner for ADASUVE in the European Union (EU), Latin America and the Commonwealth of Independent States countries. Ferrer is commercializing the product in Romania through a distribution agreement with Galenica, S.A....

2014-03-06 16:27:30

Management to Review Results and Provide Business Update in Conference Call Scheduled Today for 5:00 p.m. Eastern Time MOUNTAIN VIEW, Calif., March 6, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today reported financial results for the quarter and year ended December 31, 2013. The net loss for the fourth quarter was $5.7 million compared to $10.3 million during the same quarter in 2012. The net loss for the years ended December 31, 2013 and 2012 was $39.6 million and...

2014-03-03 08:31:55

ADASUVE is the first and only orally inhaled medicine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults MOUNTAIN VIEW, Calif., March 3, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced the U.S. commercial launch of ADASUVE(®) (loxapine) inhalation powder 10mg by its commercial partner, Teva Pharmaceutical Industries Ltd., (NYSE: TEVA). ADASUVE is the first and only orally inhaled medicine for the acute...

2014-02-25 08:33:25

MOUNTAIN VIEW, Calif., Feb. 25, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that Robert A. Lippe has joined the Company as Executive Vice President, Operations and Chief Operations Officer. In this newly created position, Mr. Lippe has responsibility for the Company's global operation functions, including strategic development and execution of clinical and commercial manufacturing, quality and compliance, supply chain and supply partner...

2014-02-20 16:26:44

MOUNTAIN VIEW, Calif., Feb. 20, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today its corporate presentation will be webcast live from two upcoming investor conferences. The webcast of each presentation may be accessed from the Investor Relations section of the Alexza Pharmaceuticals website at www.alexza.com. The conferences and presentation times are: -- Cowen & Company 34(th) Annual Health Care Conference in Boston, MA on Monday, March 3,...

2014-02-13 08:31:58

MOUNTAIN VIEW, Calif., Feb. 13, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) will report results for its fiscal year ended December 31, 2013 on Thursday, March 6, 2014, following the close of the U.S. financial markets. The Company will also host an investor conference call and live webcast on the same day at 5:00 p.m. Eastern Time / 2:00 p.m. Pacific Time to provide a company update and discuss the financial results. (Logo:...

2013-11-21 16:27:13

MOUNTAIN VIEW, Calif., Nov. 21, 2013 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that the Company will participate in the 25(th) Annual Piper Jaffray Healthcare Conference, being held in New York, NY, on December 3 - 4, 2013. Thomas B. King, Alexza President and CEO, will present at the conference. The Alexza corporate presentation will be Tuesday, December 3, 2013 at 2:30 p.m. Eastern Time. The presentation will be webcast live. To access the...